GSK, Theravance lung drug Relvar wins European green light
LONDON (Reuters) - GlaxoSmithKline and Theravance's new inhaled lung drug Relvar has been recommended for approval in Europe, Britain's biggest drugma...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/upuPHaCqjcg/story01.htm
No comments:
Post a Comment